Pattern of Cytology and Lung Biopsy Findings in Patients with Chronic Inflammation, Atypical Lesions and Cancer by Age Group

Alendra Chakramurty; Syamsul  Bahri

doi:10.37899/journallamedihealtico.v6i3.2097

Alendra Chakramurty Swadaya Gunung Jati University
Syamsul Bahri Department Anatomical Pathology, Sidawangi Hospital, West Java Province

DOI: https://doi.org/10.37899/journallamedihealtico.v6i3.2097

Keywords: Lung Disease, Cytology, Lung Biopsy, Lung Cancer, Chronic Pneumonia

Abstract

Lung diseases, both non-neoplastic such as chronic pneumonia and neoplastic such as lung cancer, have similar clinical characteristics so that they are difficult to differentiate. Cytological studies and lung biopsies are important diagnostic methods in determining the pattern of findings between the two conditions, especially when related to the patient's age group. This study used a retrospective descriptive design to analyze patterns of cytology and lung biopsy findings in patients with chronic lung inflammation, inflammation with atypical cells, and lung cancer based on age group. Data was taken from patient medical records at Sidawangi Hospital, West Java, in the period July 2024 – January 2025. Of the 109 patients who met the inclusion criteria, 87 patients were diagnosed with chronic pneumonia and 36 patients with lung cancer. The results showed that the average age of lung cancer patients was 62.78 years, while chronic lung inflammation patients had an average age of 56.12 years. Patients with atypical lesions had a mean age of 47.82 years. These findings indicate differences in cytology and lung biopsy patterns between chronic pneumonia and lung cancer patients, with a higher prevalence of lung cancer in the elderly.

References

Albano, D., Santore, L. A., Bilfinger, T., Feraca, M., Novotny, S., & Nemesure, B. (2021). Clinical implications of “atypia” on biopsy: possible precursor to lung cancer?. Current Oncology, 28(4), 2516-2522. https://doi.org/10.3390/curroncol28040228

Almadani, A., Ping, M. N., Deenadayalu, A., Saunders, J., & O’Brien, A. (2019). The effect of using different types of forceps in the efficacy of transbronchial lung biopsy. Lung, 197, 61-66. https://doi.org/10.1007/s00408-018-0179-6

Atella, V., Piano Mortari, A., Kopinska, J., Belotti, F., Lapi, F., Cricelli, C., & Fontana, L. (2019). Trends in age‐related disease burden and healthcare utilization. Aging cell, 18(1), e12861. https://doi.org/10.1111/acel.12861

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68(6), 394-424. https://doi.org/10.3322/caac.21492

Cho, S. J., & Stout-Delgado, H. W. (2020). Aging and lung disease. Annual review of physiology, 82(1), 433-459. https://doi.org/10.1146/annurev-physiol-021119-034610

Durham, A. L., & Adcock, I. M. (2015). The relationship between COPD and lung cancer. Lung cancer, 90(2), 121-127. https://doi.org/10.1016/j.lungcan.2015.08.017

Girard, N. (2023). Differential diagnosis of reciprocal mimics of neoplastic and non-neoplastic pulmonary disorders: multidisciplinary approaches. Rare Diseases of the Respiratory System: ERS Monograph 100, 10. https://doi.org/10.1183/2312508X.10017222

Greenhill, S. R. (2025). Thoracentesis Technique. In Principles and Practice of Interventional Pulmonology (pp. 1-8). Cham: Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-49583-0_68-1

Gupta, A., Omeogu, C. H., Islam, J. Y., Joshi, A. R., & Akinyemiju, T. F. (2022). Association of area‐level socioeconomic status and non–small cell lung cancer stage by race/ethnicity and health care–level factors: analysis of the National Cancer Database. Cancer, 128(16), 3099-3108. https://doi.org/10.1002/cncr.34327

Karpathiou, G., Péoc’h, M., Sundaralingam, A., Rahman, N., & Froudarakis, M. E. (2022). Inflammation of the pleural cavity: a review on pathogenesis, diagnosis and implications in tumor pathophysiology. Cancers, 14(6), 1415. https://doi.org/10.3390/cancers14061415

Kim, J. I., Park, C. M., Kim, H., Lee, J. H., & Goo, J. M. (2017). Non-specific benign pathological results on transthoracic core-needle biopsy: how to differentiate false-negatives?. European radiology, 27, 3888-3895. https://doi.org/10.1007/s00330-017-4766-3

Korsunsky, I., Wei, K., Pohin, M., Kim, E. Y., Barone, F., Major, T., ... & Raychaudhuri, S. (2022). Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases. Med, 3(7), 481-518.

Layfield, L. J., Zhang, T., Esebua, M., & Schmidt, R. L. (2021). Atypia in pulmonary cytology: A cytomorphometric analysis of the spectrum of changes between benign and malignant. Diagnostic Cytopathology, 49(8), 909-914. https://doi.org/10.1002/dc.24769

Liu, T., Liu, S., & Zhou, X. (2021). Innate immune responses and pulmonary diseases. In Lung Inflammation in Health and Disease, Volume II (pp. 53-71). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-030-68748-9_4

Molfino, N. A., & Jeffery, P. K. (2007). Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies. Pulmonary Pharmacology & Therapeutics, 20(5), 462-472. https://doi.org/10.1016/j.pupt.2006.04.003

Park, H. Y., Kang, D., Shin, S. H., Yoo, K. H., Rhee, C. K., Suh, G. Y., ... & Kwon, O. J. (2020). Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study. Thorax, 75(6), 506-509. https://doi.org/10.1136/thoraxjnl-2019-213732

Poon, I. K., Chan, R. C., Choi, J. S., Ng, J. K., Tang, K. T., Wong, Y. Y., ... & Li, J. J. (2023). A comparative study of diagnostic accuracy in 3026 pleural biopsies and matched pleural effusion cytology with clinical correlation. Cancer Medicine, 12(2), 1471-1481. https://doi.org/10.1002/cam4.5038

Rickets, W., Lau, K. K. W., Pollit, V., Mealing, S., Leonard, C., Mallender, P., ... & Naidu, U. B. (2020). Exploratory cost-effectiveness model of electromagnetic navigation bronchoscopy (ENB) compared with CT-guided biopsy (TTNA) for diagnosis of malignant indeterminate peripheral pulmonary nodules. BMJ open respiratory research, 7(1), e000595.

Safiri, S., Carson-Chahhoud, K., Noori, M., Nejadghaderi, S. A., Sullman, M. J., Heris, J. A., ... & Kaufman, J. S. (2022). Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. Bmj, 378. https://doi.org/10.1136/bmj-2021-069679

Sekhon, H. S., Souza, C. A., & Gomes, M. M. (2013). Advances in cytopathology for lung cancer: the impact and challenges of new technologies. Thoracic surgery clinics, 23(2), 163-178.

Sung, S., Heymann, J. J., Crapanzano, J. P., Moreira, A. L., Shu, C., Bulman, W. A., & Saqi, A. (2020). Lung cancer cytology and small biopsy specimens: diagnosis, predictive biomarker testing, acquisition, triage, and management. Journal of the American Society of Cytopathology, 9(5), 332-345. https://doi.org/10.1016/j.jasc.2020.04.014

Szalontai, K., Gémes, N., Furák, J., Varga, T., Neuperger, P., Balog, J. Á., ... & Szebeni, G. J. (2021). Chronic obstructive pulmonary disease: epidemiology, biomarkers, and paving the way to lung cancer. Journal of clinical medicine, 10(13), 2889. https://doi.org/10.3390/jcm10132889

Travis, W. D., & Rekhtman, N. (2011, February). Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing. In Seminars in respiratory and critical care medicine (Vol. 32, No. 01, pp. 022-031). © Thieme Medical Publishers. https://doi.org/10.1055/s-0031-1272866

Zhao, G., Li, X., Lei, S., Zhao, H., Zhang, H., & Li, J. (2022). Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Frontiers in Oncology, 12, 947981. https://doi.org/10.3389/fonc.2022.947981